Armistice Capital »

Align Technology shares owned by Armistice Capital

Quarter-by-quarter ownership of Align Technology (ALGN) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Align Technology

Tip: Access up to 7 years of quarterly data

All positions including Align Technology held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Align Technology by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $27M 158k 171.43

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Align Technology

Vanguard Group
Vanguard Capital Management
BlackRock
Capital World Investors
Capital Research and Management Company - Division 3
Vanguard Portfolio Management
State Street Corporation
Investec Asset Management
FMR
T. Rowe Price Investment Management
Goldman Sachs Group
Geode Capital Management
UBS Group
Invesco
Susquehanna International

View all funds holding Align Technology